Review





Similar Products

90
Accumetrics verifynow p2y12 analyzer
Verifynow P2y12 Analyzer, supplied by Accumetrics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2y12/verifynow+p2y12+assay/nct03373552-24-7-13
Average 90 stars, based on 1 article reviews
verifynow p2y12 analyzer - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

95
Alomone Labs rabbit anti p2ry12
Benchmarking of iMGs differentiated with neuron-compatible medium (A) Flow cytometry of hematopoietic progenitor cells (HPCs) at DIV (days in vitro ) 11 showing representative CD43 and CD45 expression (left) and quantification of percentage of positive cells, N = 5 (right). (B) Medium composition of identified neuron-compatible medium for iMG differentiation (left) and live-cell count comparison of medium compositions using flow cytometry, n = 4 replicates (right). (C) Principal-component analysis (PCA) of gene expression profiles of different cell types, based on the top 500 variable genes, N = 3–10 independent replicates (iPSCs, iMGs, iNeurons) or different donors (PMGs, cPMGs, aMACs, mono-MACs) per cell type; all samples were sequenced in the same batch. (D) Boxplots showing gene expression as transcripts per million (TPM) of key pluripotency, myeloid, and microglial markers per cell type. (E) Flow cytometry gating strategy for iMGs. (F) Bubble blot showing proteins measured with flow cytometry in iMGs differentiated with the two different media. MFI, mean fluorescence intensity; delta was calculated by subtracting the MFI of the unstained sample; % of cells = percentage of live cells positive for corresponding antibody. iMGs for data in this figure were generated from GM25256 (Coriell Institute) and AICS-0016, cl.18 (Allen Institute).
Rabbit Anti P2ry12, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2y12/Anti-P2Y12+Receptor+Antibody/pmc13555563-497-19-22
Average 95 stars, based on 1 article reviews
rabbit anti p2ry12 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

99
Oxford Instruments imaris
Benchmarking of iMGs differentiated with neuron-compatible medium (A) Flow cytometry of hematopoietic progenitor cells (HPCs) at DIV (days in vitro ) 11 showing representative CD43 and CD45 expression (left) and quantification of percentage of positive cells, N = 5 (right). (B) Medium composition of identified neuron-compatible medium for iMG differentiation (left) and live-cell count comparison of medium compositions using flow cytometry, n = 4 replicates (right). (C) Principal-component analysis (PCA) of gene expression profiles of different cell types, based on the top 500 variable genes, N = 3–10 independent replicates (iPSCs, iMGs, iNeurons) or different donors (PMGs, cPMGs, aMACs, mono-MACs) per cell type; all samples were sequenced in the same batch. (D) Boxplots showing gene expression as transcripts per million (TPM) of key pluripotency, myeloid, and microglial markers per cell type. (E) Flow cytometry gating strategy for iMGs. (F) Bubble blot showing proteins measured with flow cytometry in iMGs differentiated with the two different media. MFI, mean fluorescence intensity; delta was calculated by subtracting the MFI of the unstained sample; % of cells = percentage of live cells positive for corresponding antibody. iMGs for data in this figure were generated from GM25256 (Coriell Institute) and AICS-0016, cl.18 (Allen Institute).
Imaris, supplied by Oxford Instruments, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2y12/Imaris/custom%40imaris%4010%2E64898%2F2026%2E07%2E22%2E740167
Average 99 stars, based on 1 article reviews
imaris - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

95
Alomone Labs polyclonal rabbit anti p2ry12 antibody
Exemplary pictures of <t>P2RY12</t> expression pattern in NSCLC. a)-c) LUAD with a) absent (OD 0.08), b) weak (OD 0.15), c) moderate (OD 0.26) expression of P2RY12. Strong expression pattern was not found in LUAD. d)-g) LUSC with d) absent (OD 0.11), e) weak (OD 0.16), f) moderate (OD 0.39), g) strong (OD 0.64) expression of P2RY12. h) Normal tissue with negligible P2RY12 expression in pneumocytes. i) Normal tissue with P2RY12 expression in basal bronchial epithelium Objective Magnification: x 100 and x 400, respectively
Polyclonal Rabbit Anti P2ry12 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2y12/Anti-P2Y12+Receptor+Antibody/bio_rxiv__64898__2026__06__13__732072-44-14-20
Average 95 stars, based on 1 article reviews
polyclonal rabbit anti p2ry12 antibody - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

86
Accriva Inc verifynow p2y12
Exemplary pictures of <t>P2RY12</t> expression pattern in NSCLC. a)-c) LUAD with a) absent (OD 0.08), b) weak (OD 0.15), c) moderate (OD 0.26) expression of P2RY12. Strong expression pattern was not found in LUAD. d)-g) LUSC with d) absent (OD 0.11), e) weak (OD 0.16), f) moderate (OD 0.39), g) strong (OD 0.64) expression of P2RY12. h) Normal tissue with negligible P2RY12 expression in pneumocytes. i) Normal tissue with P2RY12 expression in basal bronchial epithelium Objective Magnification: x 100 and x 400, respectively
Verifynow P2y12, supplied by Accriva Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2y12/us12617870-216-28-38
Average 86 stars, based on 1 article reviews
verifynow p2y12 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

94
Alomone Labs anti p2y12 receptor extracellular pe antibody
Exemplary pictures of <t>P2RY12</t> expression pattern in NSCLC. a)-c) LUAD with a) absent (OD 0.08), b) weak (OD 0.15), c) moderate (OD 0.26) expression of P2RY12. Strong expression pattern was not found in LUAD. d)-g) LUSC with d) absent (OD 0.11), e) weak (OD 0.16), f) moderate (OD 0.39), g) strong (OD 0.64) expression of P2RY12. h) Normal tissue with negligible P2RY12 expression in pneumocytes. i) Normal tissue with P2RY12 expression in basal bronchial epithelium Objective Magnification: x 100 and x 400, respectively
Anti P2y12 Receptor Extracellular Pe Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2y12/Anti-P2Y12+Receptor+(extracellular)-PE+Antibody/pm41980755-59-32-37
Average 94 stars, based on 1 article reviews
anti p2y12 receptor extracellular pe antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
Alomone Labs anti p2y12 receptor antibody
Exemplary pictures of <t>P2RY12</t> expression pattern in NSCLC. a)-c) LUAD with a) absent (OD 0.08), b) weak (OD 0.15), c) moderate (OD 0.26) expression of P2RY12. Strong expression pattern was not found in LUAD. d)-g) LUSC with d) absent (OD 0.11), e) weak (OD 0.16), f) moderate (OD 0.39), g) strong (OD 0.64) expression of P2RY12. h) Normal tissue with negligible P2RY12 expression in pneumocytes. i) Normal tissue with P2RY12 expression in basal bronchial epithelium Objective Magnification: x 100 and x 400, respectively
Anti P2y12 Receptor Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2y12/Anti-P2Y12+Receptor+Antibody/pm41980755-59-70-73
Average 95 stars, based on 1 article reviews
anti p2y12 receptor antibody - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

99
Oxford Instruments microglial cells p2y12
( A ) Representative scheme of the microperfusion system. ( B ) Heat map of all ANOVA+ proteins of the LC-MS analysis of the perfusate products, ( C ) protein intensity over time, top ten upregulated genes and pathway analysis from cluster 3 and ( D ) cluster 5 in males ( n = 5 per group). ( E ) Uniform manifold approximation and projection (UMAP) plot, colored by identified clusters (different cell types). ( F ) Number of differentially expressed genes ( p < 0.05) at 24 h and 3 d after TIA in each cell type compared to control (naïve) in males ( n = 3 per group). ( G ) Volcano plot of differentially regulated genes in microglia 3 d compared to naïve animals. Cut-off for illustrating gene names: Log2FC >|2| illustrated by vertical gray dashed lines, adjusted p value: >−log10(0.05) illustrated by horizontal gray dashed line ( n = 3 per group). ( H ) Representative image and quantification of microglia (P2Y12R + ) and neuron soma (KV2.1 + ) contacts 24 h after TIA in males ( n = 5 per group; p value = 0.0079), scale bar = 20 µm. ( I ) Representative image of microglia <t>(P2Y12</t> + ) and synapse (Vglut + Homer + ) staining for synapse engulfed quantification 24 h after TIA in males ( n = 5 per group; p value = 0.0079), scale bar = 1 µm. Statistical tests: ( B – D ) Two-way ANOVA, Fisher’s exact testing. ( G ) Wilcoxon rank sum test + Bonferroni correction. ( H , I ) Two-way Student’s t -test. Error bars indicate ±SD. * p < 0.05. .
Microglial Cells P2y12, supplied by Oxford Instruments, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2y12/Imaris/pmc13083932-313-18-24
Average 99 stars, based on 1 article reviews
microglial cells p2y12 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

Image Search Results


Benchmarking of iMGs differentiated with neuron-compatible medium (A) Flow cytometry of hematopoietic progenitor cells (HPCs) at DIV (days in vitro ) 11 showing representative CD43 and CD45 expression (left) and quantification of percentage of positive cells, N = 5 (right). (B) Medium composition of identified neuron-compatible medium for iMG differentiation (left) and live-cell count comparison of medium compositions using flow cytometry, n = 4 replicates (right). (C) Principal-component analysis (PCA) of gene expression profiles of different cell types, based on the top 500 variable genes, N = 3–10 independent replicates (iPSCs, iMGs, iNeurons) or different donors (PMGs, cPMGs, aMACs, mono-MACs) per cell type; all samples were sequenced in the same batch. (D) Boxplots showing gene expression as transcripts per million (TPM) of key pluripotency, myeloid, and microglial markers per cell type. (E) Flow cytometry gating strategy for iMGs. (F) Bubble blot showing proteins measured with flow cytometry in iMGs differentiated with the two different media. MFI, mean fluorescence intensity; delta was calculated by subtracting the MFI of the unstained sample; % of cells = percentage of live cells positive for corresponding antibody. iMGs for data in this figure were generated from GM25256 (Coriell Institute) and AICS-0016, cl.18 (Allen Institute).

Journal: Stem Cell Reports

Article Title: Development and validation of a long-term co-maturation protocol for human stem cell-derived microglia and neuronal networks

doi: 10.1016/j.stemcr.2026.103053

Figure Lengend Snippet: Benchmarking of iMGs differentiated with neuron-compatible medium (A) Flow cytometry of hematopoietic progenitor cells (HPCs) at DIV (days in vitro ) 11 showing representative CD43 and CD45 expression (left) and quantification of percentage of positive cells, N = 5 (right). (B) Medium composition of identified neuron-compatible medium for iMG differentiation (left) and live-cell count comparison of medium compositions using flow cytometry, n = 4 replicates (right). (C) Principal-component analysis (PCA) of gene expression profiles of different cell types, based on the top 500 variable genes, N = 3–10 independent replicates (iPSCs, iMGs, iNeurons) or different donors (PMGs, cPMGs, aMACs, mono-MACs) per cell type; all samples were sequenced in the same batch. (D) Boxplots showing gene expression as transcripts per million (TPM) of key pluripotency, myeloid, and microglial markers per cell type. (E) Flow cytometry gating strategy for iMGs. (F) Bubble blot showing proteins measured with flow cytometry in iMGs differentiated with the two different media. MFI, mean fluorescence intensity; delta was calculated by subtracting the MFI of the unstained sample; % of cells = percentage of live cells positive for corresponding antibody. iMGs for data in this figure were generated from GM25256 (Coriell Institute) and AICS-0016, cl.18 (Allen Institute).

Article Snippet: The following primary antibodies and dilutions were used: rabbit anti-CX3CR1 (1:300, Invitrogen, PA5-19910), rat anti-TREM2 (1:300, R&D Systems, MAB17291-SP), rabbit anti-P2RY12 (1:300, Alomone Labs, APR-012), mouse anti-TMEM119 (1:300, Biolegend, A16075D), guinea pig anti-MAP2 (1:1000, Synaptic Systems, 188004), mouse anti-panAxonal (1:1000, BioLegend, 837904), rabbit anti-GFAP (1:1000; Sigma-Aldrich, AB5804), rabbit anti-Synapsin I (1:500, Sigma-Aldrich, AB1543P), mouse anti-Homer1b/c (1:200, Synaptic Systems, 160111), mouse anti-ankyrin-G (1:1000, Invitrogen, 33-800).

Techniques: Flow Cytometry, In Vitro, Expressing, Cell Characterization, Comparison, Analysis, Gene Expression, Fluorescence, Generated, IPSC, FACS

Astrocytes are required for long-term survival and integration into neuronal networks (A) Representative fluorescence microscope image of GFP-tagged hiPSC colony; scale bar, 50 μm. (B) Flow cytometry panels showing gating strategy for the detection of GFP-positive microglia in co-cultures. (C) Gene expression of myeloid and pluripotency markers across developmental timeline of iMG differentiation in monoculture, TPM, transcripts per million; N = 3 for DIV0 and DIV23, N = 2 for DIV (days in vitro ) 9 and DIV 28. (D) Quantification of iMG numbers in cultures across development, N = 2, n = 2,102 neurons for +Astro, n = 1,854 neurons for −Astro; data represent mean ± SEM, ∗ p < 0.05, ∗∗ p < 0.005, ∗∗∗∗ p < 0.0001. (E) Representative fluorescence microscope images of cultures with (+Astro) or without (−Astro) astrocytes at DIV 28; scale bars, 50 μm. (F) Cell-type composition in cultures at DIV 28 quantified by immunocytochemistry images; N = 2, n = 932 cells; data represent mean ± SEM. (G) Flow cytometry panels showing GFP-iMGs and live-cell percentages in co-cultures with or without astrocytes. (H) Representative fluorescence images of live-dead staining in co-cultures with or without astrocytes; scale bars: 100 μm (left); and quantification of cell death at DIV 22 using the integrated density of the red fluorescence; N = 1, n = 5 cultures per condition, ∗ p < 0.05 (right). iMGs for data in this figure were generated from AICS-0016; iNeurons were generated from GM25256.

Journal: Stem Cell Reports

Article Title: Development and validation of a long-term co-maturation protocol for human stem cell-derived microglia and neuronal networks

doi: 10.1016/j.stemcr.2026.103053

Figure Lengend Snippet: Astrocytes are required for long-term survival and integration into neuronal networks (A) Representative fluorescence microscope image of GFP-tagged hiPSC colony; scale bar, 50 μm. (B) Flow cytometry panels showing gating strategy for the detection of GFP-positive microglia in co-cultures. (C) Gene expression of myeloid and pluripotency markers across developmental timeline of iMG differentiation in monoculture, TPM, transcripts per million; N = 3 for DIV0 and DIV23, N = 2 for DIV (days in vitro ) 9 and DIV 28. (D) Quantification of iMG numbers in cultures across development, N = 2, n = 2,102 neurons for +Astro, n = 1,854 neurons for −Astro; data represent mean ± SEM, ∗ p < 0.05, ∗∗ p < 0.005, ∗∗∗∗ p < 0.0001. (E) Representative fluorescence microscope images of cultures with (+Astro) or without (−Astro) astrocytes at DIV 28; scale bars, 50 μm. (F) Cell-type composition in cultures at DIV 28 quantified by immunocytochemistry images; N = 2, n = 932 cells; data represent mean ± SEM. (G) Flow cytometry panels showing GFP-iMGs and live-cell percentages in co-cultures with or without astrocytes. (H) Representative fluorescence images of live-dead staining in co-cultures with or without astrocytes; scale bars: 100 μm (left); and quantification of cell death at DIV 22 using the integrated density of the red fluorescence; N = 1, n = 5 cultures per condition, ∗ p < 0.05 (right). iMGs for data in this figure were generated from AICS-0016; iNeurons were generated from GM25256.

Article Snippet: The following primary antibodies and dilutions were used: rabbit anti-CX3CR1 (1:300, Invitrogen, PA5-19910), rat anti-TREM2 (1:300, R&D Systems, MAB17291-SP), rabbit anti-P2RY12 (1:300, Alomone Labs, APR-012), mouse anti-TMEM119 (1:300, Biolegend, A16075D), guinea pig anti-MAP2 (1:1000, Synaptic Systems, 188004), mouse anti-panAxonal (1:1000, BioLegend, 837904), rabbit anti-GFAP (1:1000; Sigma-Aldrich, AB5804), rabbit anti-Synapsin I (1:500, Sigma-Aldrich, AB1543P), mouse anti-Homer1b/c (1:200, Synaptic Systems, 160111), mouse anti-ankyrin-G (1:1000, Invitrogen, 33-800).

Techniques: Fluorescence, Microscopy, Flow Cytometry, Co-Cultures, Gene Expression, In Vitro, Immunocytochemistry, Live Dead Assay, Generated, Co-Culture, FACS, RNA Sequencing, Immunofluorescence

Journal: Stem Cell Reports

Article Title: Development and validation of a long-term co-maturation protocol for human stem cell-derived microglia and neuronal networks

doi: 10.1016/j.stemcr.2026.103053

Figure Lengend Snippet:

Article Snippet: The following primary antibodies and dilutions were used: rabbit anti-CX3CR1 (1:300, Invitrogen, PA5-19910), rat anti-TREM2 (1:300, R&D Systems, MAB17291-SP), rabbit anti-P2RY12 (1:300, Alomone Labs, APR-012), mouse anti-TMEM119 (1:300, Biolegend, A16075D), guinea pig anti-MAP2 (1:1000, Synaptic Systems, 188004), mouse anti-panAxonal (1:1000, BioLegend, 837904), rabbit anti-GFAP (1:1000; Sigma-Aldrich, AB5804), rabbit anti-Synapsin I (1:500, Sigma-Aldrich, AB1543P), mouse anti-Homer1b/c (1:200, Synaptic Systems, 160111), mouse anti-ankyrin-G (1:1000, Invitrogen, 33-800).

Techniques:

Exemplary pictures of P2RY12 expression pattern in NSCLC. a)-c) LUAD with a) absent (OD 0.08), b) weak (OD 0.15), c) moderate (OD 0.26) expression of P2RY12. Strong expression pattern was not found in LUAD. d)-g) LUSC with d) absent (OD 0.11), e) weak (OD 0.16), f) moderate (OD 0.39), g) strong (OD 0.64) expression of P2RY12. h) Normal tissue with negligible P2RY12 expression in pneumocytes. i) Normal tissue with P2RY12 expression in basal bronchial epithelium Objective Magnification: x 100 and x 400, respectively

Journal: bioRxiv

Article Title: Protein expression level of P2RY12 correlates with survival in Non-Small Cell Lung Cancer and exhibits diagnostic potential for Squamous Cell Carcinomas of the Lung

doi: 10.64898/2026.06.13.732072

Figure Lengend Snippet: Exemplary pictures of P2RY12 expression pattern in NSCLC. a)-c) LUAD with a) absent (OD 0.08), b) weak (OD 0.15), c) moderate (OD 0.26) expression of P2RY12. Strong expression pattern was not found in LUAD. d)-g) LUSC with d) absent (OD 0.11), e) weak (OD 0.16), f) moderate (OD 0.39), g) strong (OD 0.64) expression of P2RY12. h) Normal tissue with negligible P2RY12 expression in pneumocytes. i) Normal tissue with P2RY12 expression in basal bronchial epithelium Objective Magnification: x 100 and x 400, respectively

Article Snippet: Sections were incubated for 60 minutes at room temperature on a shaker with a polyclonal rabbit anti-P2RY12 antibody (clone: #APR-012, Alomone labs; dilution 1:1000).

Techniques: Expressing, Tissue, Immunohistochemistry

Journal: bioRxiv

Article Title: Protein expression level of P2RY12 correlates with survival in Non-Small Cell Lung Cancer and exhibits diagnostic potential for Squamous Cell Carcinomas of the Lung

doi: 10.64898/2026.06.13.732072

Figure Lengend Snippet: Contingency table of P2RY12 eyeballing staining intensity by histological subtype (n=478 primary tumors)

Article Snippet: Sections were incubated for 60 minutes at room temperature on a shaker with a polyclonal rabbit anti-P2RY12 antibody (clone: #APR-012, Alomone labs; dilution 1:1000).

Techniques: Staining

A ) Box plots show the distribution of P2RY12 staining intensity across primary LUAD and LUSC, as well as lymph node metastases [LN] and distant metastases [DM]; B ) Box-and-whisker plots display the distribution of OD values in 38 paired samples of primary tumors (blue) and pooled metastases (yellow)

Journal: bioRxiv

Article Title: Protein expression level of P2RY12 correlates with survival in Non-Small Cell Lung Cancer and exhibits diagnostic potential for Squamous Cell Carcinomas of the Lung

doi: 10.64898/2026.06.13.732072

Figure Lengend Snippet: A ) Box plots show the distribution of P2RY12 staining intensity across primary LUAD and LUSC, as well as lymph node metastases [LN] and distant metastases [DM]; B ) Box-and-whisker plots display the distribution of OD values in 38 paired samples of primary tumors (blue) and pooled metastases (yellow)

Article Snippet: Sections were incubated for 60 minutes at room temperature on a shaker with a polyclonal rabbit anti-P2RY12 antibody (clone: #APR-012, Alomone labs; dilution 1:1000).

Techniques: Staining, Whisker Assay

( A ) Representative scheme of the microperfusion system. ( B ) Heat map of all ANOVA+ proteins of the LC-MS analysis of the perfusate products, ( C ) protein intensity over time, top ten upregulated genes and pathway analysis from cluster 3 and ( D ) cluster 5 in males ( n = 5 per group). ( E ) Uniform manifold approximation and projection (UMAP) plot, colored by identified clusters (different cell types). ( F ) Number of differentially expressed genes ( p < 0.05) at 24 h and 3 d after TIA in each cell type compared to control (naïve) in males ( n = 3 per group). ( G ) Volcano plot of differentially regulated genes in microglia 3 d compared to naïve animals. Cut-off for illustrating gene names: Log2FC >|2| illustrated by vertical gray dashed lines, adjusted p value: >−log10(0.05) illustrated by horizontal gray dashed line ( n = 3 per group). ( H ) Representative image and quantification of microglia (P2Y12R + ) and neuron soma (KV2.1 + ) contacts 24 h after TIA in males ( n = 5 per group; p value = 0.0079), scale bar = 20 µm. ( I ) Representative image of microglia (P2Y12 + ) and synapse (Vglut + Homer + ) staining for synapse engulfed quantification 24 h after TIA in males ( n = 5 per group; p value = 0.0079), scale bar = 1 µm. Statistical tests: ( B – D ) Two-way ANOVA, Fisher’s exact testing. ( G ) Wilcoxon rank sum test + Bonferroni correction. ( H , I ) Two-way Student’s t -test. Error bars indicate ±SD. * p < 0.05. .

Journal: EMBO Molecular Medicine

Article Title: Blocking microglial reactivity via purinergic receptors prevents subacute cognitive deficits after TIA

doi: 10.1038/s44321-026-00397-6

Figure Lengend Snippet: ( A ) Representative scheme of the microperfusion system. ( B ) Heat map of all ANOVA+ proteins of the LC-MS analysis of the perfusate products, ( C ) protein intensity over time, top ten upregulated genes and pathway analysis from cluster 3 and ( D ) cluster 5 in males ( n = 5 per group). ( E ) Uniform manifold approximation and projection (UMAP) plot, colored by identified clusters (different cell types). ( F ) Number of differentially expressed genes ( p < 0.05) at 24 h and 3 d after TIA in each cell type compared to control (naïve) in males ( n = 3 per group). ( G ) Volcano plot of differentially regulated genes in microglia 3 d compared to naïve animals. Cut-off for illustrating gene names: Log2FC >|2| illustrated by vertical gray dashed lines, adjusted p value: >−log10(0.05) illustrated by horizontal gray dashed line ( n = 3 per group). ( H ) Representative image and quantification of microglia (P2Y12R + ) and neuron soma (KV2.1 + ) contacts 24 h after TIA in males ( n = 5 per group; p value = 0.0079), scale bar = 20 µm. ( I ) Representative image of microglia (P2Y12 + ) and synapse (Vglut + Homer + ) staining for synapse engulfed quantification 24 h after TIA in males ( n = 5 per group; p value = 0.0079), scale bar = 1 µm. Statistical tests: ( B – D ) Two-way ANOVA, Fisher’s exact testing. ( G ) Wilcoxon rank sum test + Bonferroni correction. ( H , I ) Two-way Student’s t -test. Error bars indicate ±SD. * p < 0.05. .

Article Snippet: For the microglia-synapse analysis, confocal Z-stack images were processed, and colocalizations of synapses (VGlut+ Homer+) in contact with microglial cells (P2Y12+) were analyzed using Imaris software.

Techniques: Liquid Chromatography with Mass Spectroscopy, Control, Staining

( A ) Luciferace assay to detect ATP concentration from peri-lesional perfusate (see Fig. ) at before (BL) and at indicated time points after TIA in males ( n = 6 per group; 10 min: p value = 0.0002, 24 h: p value = 0.0231). ( B ) Quantification of extracellular ATP (hsyn-cATPs) using in vivo two-photon imaging before (BL) and at indicated time points after TIA ( n = 18 per group; 10 min: p value <0.01) and ( C ) microglial processes (Cx3Cr1cre-TdTomato) recruitment to focal increase in extracellular ATP within 3 min after TIA in males. ( D ) Representative image of Iba1+ microglia cell and 3D reconstructed microglia for branches nodes analysis 24 h after cisterna magna injection of different ATP concentrations in males ( n = 6 per group; 0.3, 1, and 3 µg ATP: p value <0.0001), scale bar = 20 µm. ( E ) Quantification of colocalized presynaptic and postsynaptic particles 24 h after cisterna magna injection of different ATP concentrations in males ( n = 6 per group; 0.3, 1, and 3 µg ATP: p value <0.0001). ( F ) Microglia sphericity ( n = 5 per group; Veh: p value <0.0001 and P2Y12Ri: p value <0.0001), ( G ) synapse (Vglut + Homer + ) contacts with microglial cells (P2Y12 + ) ( n = 10 per group; Veh: p value <0.0033 and P2Y12Ri: p value <0.0035) (scale bar = 2 µm) and ( H ) glutamatergic synapse counts ( n = 5 per group) in sham and 24 h after TIA in vehicle (Veh) or P2Y12Ri (-inhibitor) treated animals (in males’ mice); Veh: p value = 0.0140 and P2Y12Ri: p value = 0.0155. ( I ) Neuroscore at 48 h after TIA in vehicle (Veh) or P2Y12Ri (-inhibitor) treated animals ( n = 10 per group; p value = 0.0002) and ( J ) Barnes Maze test ( n = 10 per group) in Sham and 48 h after TIA in vehicle (Veh) or P2Y12Ri (-inhibitor) treated animals (in males’ mice); Veh: p value = 0.0083 and P2Y12Ri: p value = 0.0469. Statistical tests: ( A – J ) two-way ANOVA, corrected for multiple comparisons using two-stage step-up method of Benjamin Kriegel. (I) Mann–Whitney U -test. Error bars indicate ±SD. * p < 0.05. .

Journal: EMBO Molecular Medicine

Article Title: Blocking microglial reactivity via purinergic receptors prevents subacute cognitive deficits after TIA

doi: 10.1038/s44321-026-00397-6

Figure Lengend Snippet: ( A ) Luciferace assay to detect ATP concentration from peri-lesional perfusate (see Fig. ) at before (BL) and at indicated time points after TIA in males ( n = 6 per group; 10 min: p value = 0.0002, 24 h: p value = 0.0231). ( B ) Quantification of extracellular ATP (hsyn-cATPs) using in vivo two-photon imaging before (BL) and at indicated time points after TIA ( n = 18 per group; 10 min: p value <0.01) and ( C ) microglial processes (Cx3Cr1cre-TdTomato) recruitment to focal increase in extracellular ATP within 3 min after TIA in males. ( D ) Representative image of Iba1+ microglia cell and 3D reconstructed microglia for branches nodes analysis 24 h after cisterna magna injection of different ATP concentrations in males ( n = 6 per group; 0.3, 1, and 3 µg ATP: p value <0.0001), scale bar = 20 µm. ( E ) Quantification of colocalized presynaptic and postsynaptic particles 24 h after cisterna magna injection of different ATP concentrations in males ( n = 6 per group; 0.3, 1, and 3 µg ATP: p value <0.0001). ( F ) Microglia sphericity ( n = 5 per group; Veh: p value <0.0001 and P2Y12Ri: p value <0.0001), ( G ) synapse (Vglut + Homer + ) contacts with microglial cells (P2Y12 + ) ( n = 10 per group; Veh: p value <0.0033 and P2Y12Ri: p value <0.0035) (scale bar = 2 µm) and ( H ) glutamatergic synapse counts ( n = 5 per group) in sham and 24 h after TIA in vehicle (Veh) or P2Y12Ri (-inhibitor) treated animals (in males’ mice); Veh: p value = 0.0140 and P2Y12Ri: p value = 0.0155. ( I ) Neuroscore at 48 h after TIA in vehicle (Veh) or P2Y12Ri (-inhibitor) treated animals ( n = 10 per group; p value = 0.0002) and ( J ) Barnes Maze test ( n = 10 per group) in Sham and 48 h after TIA in vehicle (Veh) or P2Y12Ri (-inhibitor) treated animals (in males’ mice); Veh: p value = 0.0083 and P2Y12Ri: p value = 0.0469. Statistical tests: ( A – J ) two-way ANOVA, corrected for multiple comparisons using two-stage step-up method of Benjamin Kriegel. (I) Mann–Whitney U -test. Error bars indicate ±SD. * p < 0.05. .

Article Snippet: For the microglia-synapse analysis, confocal Z-stack images were processed, and colocalizations of synapses (VGlut+ Homer+) in contact with microglial cells (P2Y12+) were analyzed using Imaris software.

Techniques: Concentration Assay, In Vivo, Imaging, Injection, MANN-WHITNEY